RAdioGel®.
Our New Generation Cancer Treatment
Our RadioGel® division assembled a team of talented and dedicated professionals who are passionate about improving cancer treatment through cutting edge technology and an advance knowledge for innovative solutions to cancer therapy. Our team includes brilliant scientists, dedicated researchers, innovative engineers, and top notch business professionals, all of whom bring unique skills and perspectives to our work.
RadioGel® is not FDA-approved for commercial use in the United States.
The human therapy data cited is from an international clinical trial under U.S. regulatory standards.